Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasisTop-line data from the 12-week double-blind ...

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

Q4 2024 total revenues of $53.2 million, +17% compared to Q4 2023 Q4 2024 Fanapt® net product sales of $26.6 million, +18% compared to Q4 2023 Full year 2024 total ...

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...

There are just under a dozen biologics on the market for the treatment of psoriasis, with the majority available in Malaysia. One of the latest to be introduced here is the monoclonal antibody ...

Biologics are more targeted than other psoriasis treatments. They’re also more expensive, and you take them less frequently. Doctors usually prescribe them for moderate to severe psoriasis.

Patients aged 55 years and older are more likely to discontinue biologic treatment for psoriasis due to adverse events, whereas patients aged 16 to 24 years are more likely to discontinue treatment of ...

Psoriasis is a complex, chronic relapsing and inflammatory skin disorder with a prevalence of approximately 2% in the general population worldwide. Psoriasis can be triggered by infections, physical ...

5 INSERM U 1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France Objectives To assess the efficacy and the safety of biologics in a cohort of patients with relapsing ...

While you're getting treated for psoriasis, make sure you find a way to manage the stress and emotions that may tag along. Reach out to family, friends, and support groups to get the backing you need.

If you have psoriasis, you might take medication and keep close tabs on the weather, your stress level, and other triggers. Should you also watch what's on your plate? A healthy diet -- lots of ...